A patient is ineligible for treatment with the Liposonix system if any of the following criteria are met:
The Liposonix treatment is not a replacement for liposuction surgery or a healthy lifestyle, or a way to lose weight. For a full list of patient criteria and contraindications see the Liposonix System User Manual.
By utilizing heat, the Liposonix treatment creates a dual tissue response. The controlled thermal effect results in the destruction of targeted fat as well as contraction of collagen in the treatment area. (The benefit of collagen denaturization cannot be achieved with cryolipolysis or low intensity ultrasound.) The body then naturally processes and removes the destroyed fat tissue over a period of 8 to 12 weeks, which may leave patients with a slimmer, more contoured waistline.
Intended Use & Indications for Use are as follows for all countries where available, with specific indications as listed below:
The Liposonix system delivers high-intensity focused ultrasound (HIFU) energy that can disrupt subcutaneous adipose tissue (SAT) to provide a non-invasive approach to body contouring to achieve a desired aesthetic effect.
US: Indicated for non-invasive waist circumference reduction (i.e., abdomen and flanks).
Canada, Mexico: Indicated for abdomen, flanks, hips, thighs and buttocks.
Australia, EU, Taiwan: Indicated for trunk and lower extremities excluding the lower leg (i.e., abdomen, flanks, hips, thighs and buttocks).
How Liposonix WorksFind Out More >
®/™ are trademarks of Valeant Pharmaceuticals International, Inc. or its affiliates. Any other product or brand names and logos are the property of their respective owners.
© 2015 Solta Medical, a division of Valeant Pharmaceuticals North America, LLC. All rights reserved.